Syngen Biotech Co.,Ltd. (TPEX: 8279)

Syngen Biotech Co.,Ltd. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	270.59	366.89	246.05	314.8	423.42	519.39
Cash & Short-Term Investments	270.59	366.89	246.05	314.8	423.42	519.39
Cash Growth	21.71%	49.11%	-21.84%	-25.65%	-18.48%	304.05%
Accounts Receivable	508.64	387.8	472.06	388.16	298.71	299.67
Other Receivables	24	0	0	0	-	0.02
Receivables	532.64	387.8	472.06	388.16	298.71	299.69
Inventory	340.1	348.99	369.35	291.96	259.78	226.59
Prepaid Expenses	39.35	28.77	25.42	23.17	34.92	27.58
Total Current Assets	1,183	1,132	1,113	1,018	1,017	1,073
Property, Plant & Equipment	1,557	1,526	1,543	1,035	1,035	752.52
Long-Term Investments	328.59	331.74	313.75	293.55	2.7	3.06
Other Intangible Assets	24.47	24.13	22.96	23.42	27.32	29.87
Long-Term Deferred Tax Assets	18.2	17.44	16.21	12.32	10.39	9.33
Other Long-Term Assets	50.5	73.21	58.7	28.23	28.94	59.43
Total Assets	3,164	3,106	3,071	2,416	2,127	1,928
Accounts Payable	234.51	226.47	248.45	236.86	140.59	161.1
Accrued Expenses	64.11	72.8	79.89	64.72	3.94	3.29
Short-Term Debt	50	80	230	-	50	-
Current Portion of Long-Term Debt	59.03	59.03	-	-	-	-
Current Portion of Leases	14.8	13.38	14.85	13.7	14.11	11.11
Current Income Taxes Payable	31.81	62.06	76.99	58.39	28.12	34.83
Current Unearned Revenue	34.62	20.04	6.73	6.55	1.97	2.63
Other Current Liabilities	200.59	50.81	62.56	38.4	73.27	79.68
Total Current Liabilities	689.47	584.58	719.47	418.61	312	292.64
Long-Term Debt	193.46	222.97	182	50	-	-
Long-Term Leases	167.77	163.1	173.93	172.39	186.17	142.3
Long-Term Deferred Tax Liabilities	4.03	3.98	3.93	3.16	2.58	2.05
Other Long-Term Liabilities	-	-	-	-	-	0.02
Total Liabilities	1,055	974.63	1,079	644.16	500.74	437.01
Common Stock	271.01	271.01	271.01	271.01	271.01	271.01
Additional Paid-In Capital	618.24	618.2	618.06	612.83	610.54	610.54
Retained Earnings	1,217	1,243	1,103	887.88	744.67	609.94
Comprensive Income & Other	3.78	-0.26	-0.07	-0.36	-0.12	0
Shareholders' Equity	2,110	2,132	1,992	1,771	1,626	1,491
Total Liabilities & Equity	3,164	3,106	3,071	2,416	2,127	1,928
Total Debt	485.06	538.49	600.78	236.08	250.28	153.41
Net Cash (Debt)	-214.47	-171.6	-354.73	78.72	173.14	365.98
Net Cash Growth	-	-	-	-54.53%	-52.69%	-
Net Cash Per Share	-7.91	-6.33	-13.07	2.90	6.38	15.22
Filing Date Shares Outstanding	27.1	27.1	27.1	27.1	27.1	27.1
Total Common Shares Outstanding	27.1	27.1	27.1	27.1	27.1	27.1
Working Capital	493.2	547.87	393.41	599.48	704.84	780.62
Book Value Per Share	77.84	78.66	73.49	65.36	60.00	55.03
Tangible Book Value	2,085	2,107	1,969	1,748	1,599	1,462
Tangible Book Value Per Share	76.94	77.76	72.64	64.50	58.99	53.93
Land	251	251	251	-	-	-
Buildings	728.58	717.09	702.28	532.98	529.5	378.36
Machinery	963.54	871.44	841.51	693.37	656.19	559.92
Construction In Progress	114.01	146.33	114.01	111.97	79.98	33.17

Source: S&P Capital IQ. Standard template. Financial Sources.